| central nervous system neuron differentiation | GO:0021953 | 162 | 0.836 | |
| neuron migration | GO:0001764 | 122 | 0.815 | Mouse |
| axonogenesis | GO:0007409 | 274 | 0.686 | |
| regulation of saliva secretion | GO:0046877 | 2 | 0.632 | |
| spinal cord development | GO:0021510 | 81 | 0.628 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.612 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.611 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.610 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.601 | |
| forebrain development | GO:0030900 | 302 | 0.577 | |
| adult behavior | GO:0030534 | 135 | 0.556 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.526 | Mouse |
| negative regulation of serotonin secretion | GO:0014063 | 2 | 0.519 | |
| hormone secretion | GO:0046879 | 128 | 0.482 | |
| postganglionic parasympathetic nervous system development | GO:0021784 | 2 | 0.474 | |
| sensory perception | GO:0007600 | 245 | 0.469 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.464 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.458 | |
| gtp metabolic process | GO:0046039 | 144 | 0.455 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.437 | |
| regionalization | GO:0003002 | 337 | 0.427 | |
| neuron projection extension | GO:1990138 | 64 | 0.414 | |
| neuron projection guidance | GO:0097485 | 141 | 0.410 | |
| forebrain cell migration | GO:0021885 | 58 | 0.405 | |
| developmental maturation | GO:0021700 | 193 | 0.397 | |
| gland development | GO:0048732 | 330 | 0.395 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.393 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.391 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.386 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.377 | |
| chemotaxis | GO:0006935 | 247 | 0.377 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.366 | |
| membrane depolarization | GO:0051899 | 64 | 0.356 | |
| negative regulation of axon guidance | GO:1902668 | 8 | 0.323 | |
| gtp catabolic process | GO:0006184 | 143 | 0.323 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.322 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.318 | |
| motor neuron axon guidance | GO:0008045 | 26 | 0.313 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.307 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.300 | |
| hexose metabolic process | GO:0019318 | 98 | 0.299 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.297 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.296 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.293 | |
| cation transport | GO:0006812 | 399 | 0.292 | |
| forebrain neuron development | GO:0021884 | 30 | 0.290 | |
| regulation of excitatory postsynaptic membrane potential | GO:0060079 | 41 | 0.289 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.288 | |
| negative regulation of adenylate cyclase activity | GO:0007194 | 1 | 0.282 | |
| endocrine pancreas development | GO:0031018 | 29 | 0.281 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.273 | |
| transmembrane transport | GO:0055085 | 412 | 0.272 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.271 | |
| learning | GO:0007612 | 98 | 0.270 | |
| neuron neuron synaptic transmission | GO:0007270 | 69 | 0.267 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.262 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.260 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.260 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.257 | |
| positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway | GO:0010579 | 3 | 0.253 | |
| somatostatin receptor signaling pathway | GO:0038169 | 2 | 0.252 | |
| axon guidance | GO:0007411 | 141 | 0.249 | |
| regulation of system process | GO:0044057 | 200 | 0.244 | |
| ossification | GO:0001503 | 216 | 0.244 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.243 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.241 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.240 | |
| blood circulation | GO:0008015 | 195 | 0.238 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.229 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.226 | |
| developmental cell growth | GO:0048588 | 84 | 0.226 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.225 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.224 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.221 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.219 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.218 | |
| cerebral cortex cell migration | GO:0021795 | 44 | 0.215 | |
| regulation of cell size | GO:0008361 | 72 | 0.214 | |
| epithelial tube formation | GO:0072175 | 130 | 0.211 | |
| kidney development | GO:0001822 | 213 | 0.211 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.211 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.210 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.210 | |
| stem cell differentiation | GO:0048863 | 268 | 0.208 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.205 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.203 | |
| synaptic transmission | GO:0007268 | 329 | 0.200 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.198 | |
| nerve development | GO:0021675 | 67 | 0.198 | |
| negative regulation of axon extension | GO:0030517 | 19 | 0.196 | |
| telencephalon development | GO:0021537 | 186 | 0.194 | |
| glucose homeostasis | GO:0042593 | 128 | 0.192 | |
| negative regulation of lyase activity | GO:0051350 | 1 | 0.191 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.191 | |
| regulation of ion transport | GO:0043269 | 215 | 0.189 | |
| metencephalon development | GO:0022037 | 89 | 0.188 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.188 | |
| insulin secretion | GO:0030073 | 89 | 0.186 | |
| locomotory behavior | GO:0007626 | 195 | 0.180 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.177 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.176 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.174 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.174 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.173 | |
| glutamate receptor signaling pathway | GO:0007215 | 35 | 0.173 | |
| ventral spinal cord interneuron fate commitment | GO:0060579 | 14 | 0.171 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.170 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.169 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.169 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.168 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.168 | |
| bone mineralization | GO:0030282 | 54 | 0.168 | |
| amide transport | GO:0042886 | 138 | 0.167 | |
| regulation of secretion | GO:0051046 | 274 | 0.166 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.166 | |
| conditioned taste aversion | GO:0001661 | 4 | 0.165 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.165 | |
| gastrin induced gastric acid secretion | GO:0001698 | 1 | 0.163 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.163 | |
| somatotropin secreting cell development | GO:0060133 | 2 | 0.161 | |
| camp metabolic process | GO:0046058 | 40 | 0.161 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.160 | |
| cerebellum development | GO:0021549 | 77 | 0.157 | |
| associative learning | GO:0008306 | 61 | 0.157 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.157 | |
| autonomic nervous system development | GO:0048483 | 43 | 0.156 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.155 | |
| phasic smooth muscle contraction | GO:0014821 | 8 | 0.154 | |
| defecation | GO:0030421 | 1 | 0.153 | |
| peptide secretion | GO:0002790 | 114 | 0.153 | |
| regulation of axon guidance | GO:1902667 | 13 | 0.150 | |
| urogenital system development | GO:0001655 | 261 | 0.150 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.149 | |
| spinal cord dorsal ventral patterning | GO:0021513 | 23 | 0.147 | |
| cation homeostasis | GO:0055080 | 212 | 0.147 | |
| membrane organization | GO:0061024 | 245 | 0.147 | |
| ectoderm formation | GO:0001705 | 3 | 0.147 | |
| spinal cord patterning | GO:0021511 | 25 | 0.146 | |
| oviduct development | GO:0060066 | 3 | 0.146 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.146 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.145 | Mouse |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.144 | |
| skeletal system development | GO:0001501 | 356 | 0.144 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.144 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.143 | |
| maintenance of cell number | GO:0098727 | 3 | 0.142 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.142 | |
| cell growth | GO:0016049 | 130 | 0.142 | |
| histamine induced gastric acid secretion | GO:0001697 | 1 | 0.140 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.139 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.139 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.139 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.138 | |
| hindbrain development | GO:0030902 | 128 | 0.136 | |
| cranial nerve development | GO:0021545 | 41 | 0.135 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.133 | |
| cellular response to temperature stimulus | GO:0071502 | 2 | 0.133 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.132 | |
| tissue remodeling | GO:0048771 | 102 | 0.132 | |
| regulation of axon extension | GO:0030516 | 43 | 0.131 | |
| synapse assembly | GO:0007416 | 56 | 0.131 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.130 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.130 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.130 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.126 | |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.126 | |
| general adaptation syndrome | GO:0051866 | 2 | 0.126 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.126 | |
| sensory perception of pain | GO:0019233 | 47 | 0.124 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.124 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.120 | |
| response to monosaccharide | GO:0034284 | 67 | 0.119 | |
| regulation of lyase activity | GO:0051339 | 13 | 0.118 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.116 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.116 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.114 | |
| cellular homeostasis | GO:0019725 | 240 | 0.114 | |
| ventral spinal cord development | GO:0021517 | 48 | 0.114 | |
| negative regulation of growth | GO:0045926 | 99 | 0.114 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.113 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.112 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.112 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.112 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.111 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.111 | |
| angiogenesis | GO:0001525 | 201 | 0.110 | |
| pallium development | GO:0021543 | 120 | 0.109 | |
| response to peptide | GO:1901652 | 136 | 0.109 | Mouse |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.108 | |
| cell adhesion | GO:0007155 | 329 | 0.108 | |
| learning or memory | GO:0007611 | 148 | 0.108 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.107 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.106 | Mouse |
| cellular polysaccharide metabolic process | GO:0044264 | 38 | 0.106 | |
| dendrite development | GO:0016358 | 115 | 0.102 | |
| response to peptide hormone | GO:0043434 | 127 | 0.102 | Mouse |
| neural tube development | GO:0021915 | 160 | 0.102 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.102 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.102 | |
| neural crest cell development | GO:0014032 | 48 | 0.101 | |
| rhythmic process | GO:0048511 | 174 | 0.101 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.100 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.099 | |
| ventral spinal cord interneuron differentiation | GO:0021514 | 16 | 0.099 | |
| biomineral tissue development | GO:0031214 | 64 | 0.099 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.099 | |
| heart contraction | GO:0060047 | 93 | 0.099 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.098 | |
| negative regulation of blood pressure | GO:0045776 | 22 | 0.098 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.098 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.098 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.098 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.097 | |
| corticosterone secretion | GO:0035934 | 3 | 0.097 | |
| neural tube formation | GO:0001841 | 108 | 0.097 | |
| stem cell proliferation | GO:0072089 | 117 | 0.096 | |
| regulation of cyclase activity | GO:0031279 | 13 | 0.096 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.095 | |
| glucose import | GO:0046323 | 32 | 0.094 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.094 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.093 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.093 | |
| regulation of synaptic transmission glutamatergic | GO:0051966 | 19 | 0.093 | |
| atrioventricular node cell fate commitment | GO:0060929 | 1 | 0.093 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.093 | |
| circulatory system process | GO:0003013 | 197 | 0.092 | |
| hippocampus development | GO:0021766 | 52 | 0.092 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.092 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.091 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.090 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.089 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.089 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.088 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.087 | |
| renal system development | GO:0072001 | 225 | 0.087 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.087 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.086 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.086 | |
| positive regulation of heart rate by epinephrine norepinephrine | GO:0001996 | 4 | 0.086 | |
| positive regulation of renal sodium excretion | GO:0035815 | 2 | 0.086 | |
| diencephalon development | GO:0021536 | 63 | 0.086 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.085 | |
| adenylate cyclase inhibiting g protein coupled receptor signaling pathway | GO:0007193 | 20 | 0.084 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.084 | |
| mapk cascade | GO:0000165 | 281 | 0.084 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.084 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.084 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.083 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.083 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.083 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.082 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.082 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.082 | |
| synaptic transmission glutamatergic | GO:0035249 | 36 | 0.082 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.082 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.082 | |
| cell maturation | GO:0048469 | 127 | 0.081 | |
| positive regulation of the force of heart contraction by epinephrine norepinephrine | GO:0001997 | 3 | 0.081 | |
| neural tube patterning | GO:0021532 | 43 | 0.080 | |
| pancreas development | GO:0031016 | 57 | 0.080 | |
| mucosal associated lymphoid tissue development | GO:0048537 | 12 | 0.080 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.080 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.080 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.080 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.080 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.079 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.079 | |
| ear development | GO:0043583 | 200 | 0.079 | |
| synapse organization | GO:0050808 | 125 | 0.079 | |
| endocrine system development | GO:0035270 | 98 | 0.077 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.077 | |
| cerebellar cortex morphogenesis | GO:0021696 | 32 | 0.077 | |
| digestive system development | GO:0055123 | 200 | 0.076 | |
| cardiac septum development | GO:0003279 | 59 | 0.076 | |
| peptide transport | GO:0015833 | 133 | 0.076 | |
| branchiomotor neuron axon guidance | GO:0021785 | 7 | 0.076 | |
| epithelial cell development | GO:0002064 | 159 | 0.075 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.075 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.075 | |
| regulation of cell growth | GO:0001558 | 91 | 0.075 | |
| cerebral cortex development | GO:0021987 | 86 | 0.074 | |
| appendage development | GO:0048736 | 166 | 0.074 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.074 | |
| substrate independent telencephalic tangential migration | GO:0021826 | 8 | 0.073 | |
| neuron death | GO:0070997 | 154 | 0.073 | |
| glucan metabolic process | GO:0044042 | 32 | 0.073 | |
| formation of organ boundary | GO:0010160 | 1 | 0.073 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.073 | |
| negative regulation of camp mediated signaling | GO:0043951 | 3 | 0.073 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.073 | |
| glycogen metabolic process | GO:0005977 | 32 | 0.073 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.073 | |
| neural tube closure | GO:0001843 | 90 | 0.072 | |
| body fluid secretion | GO:0007589 | 53 | 0.072 | |
| g protein coupled receptor internalization | GO:0002031 | 3 | 0.072 | |
| regulation of systemic arterial blood pressure by norepinephrine epinephrine | GO:0001993 | 8 | 0.071 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.071 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.071 | |
| somatostatin signaling pathway | GO:0038170 | 2 | 0.071 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.071 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 26 | 0.071 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.070 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.070 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.070 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.070 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.070 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.070 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.069 | |
| central nervous system neuron axonogenesis | GO:0021955 | 28 | 0.069 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.069 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.069 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.069 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.069 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.068 | |
| fear response | GO:0042596 | 33 | 0.068 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.067 | |
| primary neural tube formation | GO:0014020 | 95 | 0.067 | |
| cerebellar cortex formation | GO:0021697 | 22 | 0.067 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.067 | |
| pituitary gland development | GO:0021983 | 38 | 0.067 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.067 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.066 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.066 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.066 | |
| positive regulation of the force of heart contraction by chemical signal | GO:0003099 | 3 | 0.065 | |
| amine metabolic process | GO:0009308 | 45 | 0.064 | |
| stem cell development | GO:0048864 | 219 | 0.064 | |
| positive regulation of transcription by glucose | GO:0046016 | 3 | 0.064 | |
| limbic system development | GO:0021761 | 72 | 0.064 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.064 | |
| adenohypophysis development | GO:0021984 | 14 | 0.064 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.063 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.063 | |
| tube closure | GO:0060606 | 91 | 0.063 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.063 | |
| calcium ion transport | GO:0006816 | 159 | 0.062 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.062 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.062 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.061 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.061 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.061 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.061 | |
| forebrain neuron fate commitment | GO:0021877 | 13 | 0.061 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.060 | |
| semaphorin plexin signaling pathway involved in bone trabecula morphogenesis | GO:1900220 | 2 | 0.060 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.060 | |
| catecholamine transport | GO:0051937 | 21 | 0.060 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.060 | |
| compound eye development | GO:0048749 | 1 | 0.060 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.060 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.059 | |
| grooming behavior | GO:0007625 | 16 | 0.059 | |
| regulation of generation of precursor metabolites and energy | GO:0043467 | 38 | 0.059 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.059 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.059 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.058 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.058 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.058 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.058 | |
| connective tissue development | GO:0061448 | 179 | 0.057 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.057 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.057 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.057 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.057 | |
| regulation of ossification | GO:0030278 | 112 | 0.057 | |
| substrate independent telencephalic tangential interneuron migration | GO:0021843 | 8 | 0.057 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.057 | |
| operant conditioning | GO:0035106 | 2 | 0.057 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.056 | |
| endocrine hormone secretion | GO:0060986 | 15 | 0.056 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.056 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.055 | |
| wnt signaling pathway planar cell polarity pathway | GO:0060071 | 27 | 0.055 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.055 | |
| sympathetic nervous system development | GO:0048485 | 22 | 0.055 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.055 | |
| glucose metabolic process | GO:0006006 | 92 | 0.054 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.054 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.054 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.054 | |
| axon extension involved in axon guidance | GO:0048846 | 14 | 0.054 | |
| dorsal ventral axon guidance | GO:0033563 | 3 | 0.053 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.053 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.053 | |
| regulation of glycogen metabolic process | GO:0070873 | 13 | 0.053 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.053 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.053 | |
| auditory receptor cell fate determination | GO:0042668 | 3 | 0.053 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.052 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.052 | |
| t cell activation | GO:0042110 | 289 | 0.052 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.052 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.052 | |
| hair follicle development | GO:0001942 | 85 | 0.052 | |
| positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | GO:0072108 | 3 | 0.052 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.052 | |
| protein localization to membrane | GO:0072657 | 108 | 0.052 | |
| regulation of long term neuronal synaptic plasticity | GO:0048169 | 19 | 0.051 | |
| phospholipase c activating serotonin receptor signaling pathway | GO:0007208 | 1 | 0.051 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.051 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.051 | |
| neuropeptide signaling pathway | GO:0007218 | 19 | 0.051 | |
| regulation of interleukin 1 production | GO:0032652 | 26 | 0.051 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.050 | |
| response to alkaloid | GO:0043279 | 34 | 0.050 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.050 | |
| interleukin 1 production | GO:0032612 | 31 | 0.050 | |
| pyruvate metabolic process | GO:0006090 | 28 | 0.050 | |
| regulation of serotonin secretion | GO:0014062 | 3 | 0.050 | |
| response to pain | GO:0048265 | 26 | 0.050 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.050 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.050 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.050 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.049 | |
| regulation of interleukin 1 beta production | GO:0032651 | 25 | 0.049 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.049 | |
| renal outer medulla development | GO:0072054 | 2 | 0.049 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.049 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.049 | |
| placenta development | GO:0001890 | 140 | 0.049 | |
| mesenchyme development | GO:0060485 | 152 | 0.049 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.048 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.048 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.048 | |
| general adaptation syndrome behavioral process | GO:0051867 | 1 | 0.048 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.048 | |
| glial cell differentiation | GO:0010001 | 131 | 0.048 | |
| nephric duct formation | GO:0072179 | 4 | 0.048 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.048 | |
| hemostasis | GO:0007599 | 78 | 0.047 | |
| gliogenesis | GO:0042063 | 141 | 0.047 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.047 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.047 | |
| cerebellum formation | GO:0021588 | 1 | 0.047 | |
| ureteric bud development | GO:0001657 | 94 | 0.047 | |
| dorsal ventral neural tube patterning | GO:0021904 | 28 | 0.047 | |
| bone development | GO:0060348 | 120 | 0.047 | |
| trunk neural crest cell migration | GO:0036484 | 4 | 0.047 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.047 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.047 | |
| regulation of neuron death | GO:1901214 | 134 | 0.046 | |
| nephron tubule development | GO:0072080 | 84 | 0.046 | |
| regulation of glial cell differentiation | GO:0045685 | 41 | 0.046 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.046 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.046 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.046 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.046 | |
| optic nerve development | GO:0021554 | 8 | 0.045 | |
| labyrinthine layer blood vessel development | GO:0060716 | 21 | 0.045 | |
| spemann organizer formation | GO:0060061 | 2 | 0.045 | |
| sensitization | GO:0046960 | 2 | 0.045 | |
| regulation of cyclic nucleotide biosynthetic process | GO:0030802 | 31 | 0.045 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.045 | |
| negative regulation of cellular carbohydrate metabolic process | GO:0010677 | 19 | 0.045 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.045 | |
| regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway | GO:0010578 | 3 | 0.045 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.045 | |
| cognition | GO:0050890 | 149 | 0.045 | |
| protein targeting | GO:0006605 | 143 | 0.045 | |
| cell differentiation in hindbrain | GO:0021533 | 24 | 0.044 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.044 | |
| neural crest cell migration | GO:0001755 | 32 | 0.044 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.044 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.044 | |
| protein secretion | GO:0009306 | 111 | 0.044 | |
| monoamine transport | GO:0015844 | 33 | 0.044 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.044 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.044 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.044 | |
| epidermis development | GO:0008544 | 187 | 0.044 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.044 | |
| neuron fate specification | GO:0048665 | 30 | 0.044 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.044 | |
| positive regulation of growth hormone secretion | GO:0060124 | 3 | 0.044 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.043 | |
| cell fate commitment | GO:0045165 | 210 | 0.043 | |
| gonad development | GO:0008406 | 141 | 0.043 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.043 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.043 | |
| heart morphogenesis | GO:0003007 | 178 | 0.043 | |
| regulation of adenylate cyclase activity | GO:0045761 | 10 | 0.043 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.043 | |
| regulation of corticosterone secretion | GO:2000852 | 2 | 0.043 | |
| positive regulation of synaptic transmission glutamatergic | GO:0051968 | 8 | 0.043 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.042 | |
| positive regulation of cyclic nucleotide metabolic process | GO:0030801 | 24 | 0.042 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.042 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.042 | |
| nephron development | GO:0072006 | 109 | 0.042 | |
| cytokine production | GO:0001816 | 319 | 0.042 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 49 | 0.042 | |
| hindbrain formation | GO:0021576 | 1 | 0.042 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.041 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.041 | |
| tube formation | GO:0035148 | 140 | 0.041 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.041 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.041 | |
